Search Result "oxypurinol"


Acute Effects of Oral Tofisopam on Plasma Concentration and Urinary Excretion of Uric Acid and Oxypurinol “Preliminary Communication”

Journal: Current Clinical Pharmacology
Volume: 10 Issue: 2 Year: 2015 Page: 160-164
Author(s): Miki Hatayama,Chihiro Sumida,Masafumi Kurajoh,Jun Shiraishi,Hirokazu Okazaki,Takuhito Shoji,Hidenori Koyama,Zenta Tsutsumi,Yuji Moriwaki,Mitsuyoshi Namba,Tetsuya Yamamoto

Perspective

Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the “Cytokine Release (Storm) Syndrome” Caused by SARS-CoV-2?

Journal: Current Pharmaceutical Design
Volume: 26 Issue: 3 Year: 2020 Page: 4515-4521
Author(s): Francisco José López-Iranzo,Ana María López-Rodas,Luis Franco,Gerardo López-Rodas

Research Article

In Silico Analyses, Bioequivalence and Disposition Kinetics of Allopurinol in Healthy Male Subjects

Journal: Drug Delivery Letters
Volume: 6 Issue: 2 Year: 2016 Page: 113-121
Author(s): Sheikh A. Sehgal,Seemab A.F. Khan

Research Article

The Effects of Special Patient Population Plasma on Pharmacokinetic Quantifications Using LC-MS/MS

Journal: Drug Metabolism Letters
Volume: 13 Issue: 2 Year: 2019 Page: 111-122
Author(s): Dongmei Zhou,Lifang Sun,Mai Nguyen,Li- Tain Yeh,David M. Wilson

Xanthine Oxidase Inhibitors the Unappreciated Treatment for Heart Failure

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 7 Issue: 4 Year: 2007 Page: 291-294
Author(s): Myrvin H. Ellestad

Novel Therapeutic Agents for Hyperuricemia in Patients with Gout

Journal: Current Drug Therapy
Volume: 1 Issue: 2 Year: 2006 Page: 221-229
Author(s): Geoffrey C. Wall, Carrie F. Koenigsfeld, Kristin S. Meyer

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 2432-2438
Author(s): Davide Grassi, Livia Ferri, Giovambattista Desideri, Paolo Di Giosia, Paola Cheli, Rita Del Pinto, Giuliana Properzi, Claudio Ferri

Review Article

Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 23 Year: 2017 Page: 3391-3404
Author(s): Mirjam Schuchardt,Jaqueline Herrmann,Markus Tolle,Markus van der Giet

The Pathophysiology of Uric Acid in Relation to Cardiovascular Disease

Journal: Current Cardiology Reviews
Volume: 3 Issue: 2 Year: 2007 Page: 99-103
Author(s): Matiullah Naqibullah, Maiken J. Calberg, Erik Kjoller

Effects of Switching from Allopurinol to Febuxostat in Chronic Kidney Disease Patients

Ebook: Advances in Modern Medicine

Volume: 1 Year: 2017
Author(s): Shunsuke Takahashi,Ayumu Nakashima,Asako Urabe,Yosuke Osaki,Takao Masaki
Doi: 10.2174/9781681080239117010036

Previous   Next

Go To   Results 1 - 1 of 80

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy